Voyager Therapeutics (VYGR) Balance Sheet: Assets & Liabilities

Voyager Therapeutics (VYGR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Voyager Therapeutics reported total assets of $252.28M and total liabilities of $56.20M. Shareholders' equity was $196.08M, down 34.6% from $299.76M a year earlier. Total debt stood at $36.50M against $196.45M in cash and short-term investments, a net cash position of $159.95M. That puts debt-to-equity at 0.19, compared with 0.15 a year earlier.

Voyager Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Voyager Therapeutics, Inc. (VYGR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	65.30	71.37	68.80	98.96	117.43	104.44	86.04	46.86	31.53
Short-Term Investments	131.15	195.32	162.07	19.89	15.11	76.70	195.49	108.95	137.52
Cash & Short-Term Investments	196.45	266.68	230.88	118.85	132.54	181.14	281.53	155.81	169.05
Accounts Receivable	1.76	2.18	83.49	0.64	0.73	8.11	18.70	0.20	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	2.20	5.11	1.85
Other Current Assets	4.48	7.95	5.32	5.01	1.70	1.46	1.95	6.47	3.50
Total Current Assets	202.69	276.81	319.68	124.50	136.70	197.77	304.66	162.48	171.79
Non-Current Assets
Property, Plant & Equipment (Net)	41.61	47.66	30.00	33.34	55.38	61.50	46.46	12.77	10.28
Long-Term Investments	0.00	65.70	0.00	0.00	0.00	0.00	1.92	0.63	1.10
Other Non-Current Assets	7.98	2.87	1.59	1.52	1.78	2.32	1.72	1.15	1.30
Total Non-Current Assets	49.59	116.24	31.60	34.86	57.16	63.82	50.10	14.55	12.69
Total Assets	252.28	393.05	351.28	159.36	193.86	261.58	354.76	177.03	184.48
Current Liabilities
Accounts Payable	5.01	4.00	1.60	2.57	0.57	0.63	4.07	1.04	1.02
Short-Term Debt	7.84	7.23	3.20	2.83	5.57	4.20	3.19	0.00	0.00
Accrued Liabilities	12.10	14.17	16.82	7.82	5.93	14.21	-	-	-
Deferred Revenue	1.59	24.39	42.88	59.38	33.89	7.73	47.23	20.85	3.38
Other Current Liabilities	12.10	14.17	16.82	7.82	10.95	21.93	21.52	9.79	11.50
Total Current Liabilities	26.54	49.79	64.51	72.59	50.98	26.77	76.01	31.67	15.90
Non-Current Liabilities
Long-Term Debt	28.66	36.50	17.09	20.29	38.61	43.41	30.98	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	-47.23	0.00	0.00
Other Non-Current Liabilities	1.00	7.00	33.36	1.00	1.00	1.00	1.00	6.71	6.35
Total Non-Current Liabilities	29.66	43.50	50.45	27.75	47.82	80.50	179.24	98.91	34.53
Total Liabilities	56.20	93.29	114.96	100.34	98.80	107.26	255.25	130.58	50.43
Stockholders' Equity
Common Stock	0.06	0.06	0.04	0.04	0.04	0.04	0.04	0.03	0.03
Retained Earnings	-445.91	-326.18	-261.18	-393.51	-347.10	-275.91	-312.65	-269.05	-160.71
Accumulated Other Comprehensive Income	0.03	-0.41	-0.05	-0.22	-0.14	-0.13	-0.10	-0.13	-0.29
Additional Paid-in Capital	641.90	626.30	497.51	452.71	442.26	430.32	412.23	315.60	295.02
Shares Outstanding	59.05	54.73	44.04	38.61	37.92	-	-	-	-
Total Stockholders' Equity	196.08	299.76	236.32	59.02	95.06	154.32	99.51	46.45	134.05
Total Liabilities & Equity	252.28	393.05	351.28	159.36	193.86	261.58	354.76	177.03	184.48

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Voyager Therapeutics Balance Sheet

How much debt does Voyager Therapeutics have?

Voyager Therapeutics had total debt of $36.50M as of Dec 31, 2025, against $196.45M in cash and short-term investments. Its debt-to-equity ratio was 0.19. Total debt was $43.73M a year earlier.

What are Voyager Therapeutics's total assets?

Voyager Therapeutics reported total assets of $252.28M as of Dec 31, 2025, down 35.8% from $393.05M a year earlier. Total liabilities were $56.20M.

What is Voyager Therapeutics's shareholders' equity?

Voyager Therapeutics's shareholders' equity was $196.08M as of Dec 31, 2025, or about $3.32 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition